Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV (Metastatic) Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06439693
What this trial is testing

The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer

Who this might be right for
Breast Cancer FemaleBreast CancerBreast Cancer Metastatic+3 more
Dana-Farber Cancer Institute 72
Early research (Phase 1)Study completedNCT00004095
What this trial is testing

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+3 more
Northwestern University 38
Testing effectiveness (Phase 2)Study completedNCT00301899
What this trial is testing

Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab

Who this might be right for
Breast Cancer
National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)Study completedNCT00003612
What this trial is testing

Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 92
Testing effectiveness (Phase 2)Study completedNCT00992602
What this trial is testing

Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer

Who this might be right for
Central Nervous System MetastasesLeptomeningeal MetastasesRecurrent Breast Cancer+2 more
University of Washington 3
Testing effectiveness (Phase 2)Ended earlyNCT04123704
What this trial is testing

Sitravatinib in Metastatic Breast Cancer

Who this might be right for
Breast Cancer Stage IVTriple Negative Breast CancerBreast Neoplasms+1 more
Xiang Zhang 3
Not applicableStudy completedNCT00897338
What this trial is testing

Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 43
Testing effectiveness (Phase 2)Study completedNCT00033514
What this trial is testing

Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression

Who this might be right for
Breast Cancer
Jonsson Comprehensive Cancer Center 27
Not applicableWithdrawnNCT00898612
What this trial is testing

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Lymphoma
Mayo Clinic
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Early research (Phase 1)Study completedNCT01434303
What this trial is testing

Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only

Who this might be right for
HER2/Neu PositiveInvasive Breast CarcinomaRecurrent Breast Carcinoma+1 more
National Cancer Institute (NCI) 37
Early research (Phase 1)Looking for participantsNCT06678269
What this trial is testing

Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerStage IV Breast CancerBreast Cancer+5 more
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00399529
What this trial is testing

Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Very early researchEnded earlyNCT03796273
What this trial is testing

Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8AstrocytomaBreast Carcinoma Metastatic in the Brain+5 more
Wake Forest University Health Sciences 15
Testing effectiveness (Phase 2)Study completedNCT00967031
What this trial is testing

Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases

Who this might be right for
Breast CancerMetastatic Cancer
UNICANCER 45
Testing effectiveness (Phase 2)Ended earlyNCT03101748
What this trial is testing

Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Inflammatory CarcinomaLocally Advanced Breast CarcinomaMetastatic Breast Carcinoma+5 more
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Ended earlyNCT00088985
What this trial is testing

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT02418689
What this trial is testing

Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens

Who this might be right for
Metastatic Breast Cancer
Hanmi Pharmaceutical Company Limited 106
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT00622466
What this trial is testing

Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 20
Next Page